ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Aptamer-Engineered Liposomal Platform Enables in Situ cDC1 Vaccination to Potentiate Immunotherapy in Prostate Cancer.

Jiayi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.